NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.600
-0.120 (-4.41%)
Feb 19, 2025, 12:30 PM EST - Market open

NRx Pharmaceuticals Statistics

Total Valuation

NRXP has a market cap or net worth of $31.36 million. The enterprise value is $37.19 million.

Market Cap 31.36M
Enterprise Value 37.19M

Important Dates

The next estimated earnings date is Thursday, March 27, 2025, after market close.

Earnings Date Mar 27, 2025
Ex-Dividend Date n/a

Share Statistics

NRXP has 12.06 million shares outstanding. The number of shares has increased by 32.95% in one year.

Current Share Class 12.06M
Shares Outstanding 12.06M
Shares Change (YoY) +32.95%
Shares Change (QoQ) +4.34%
Owned by Insiders (%) 15.77%
Owned by Institutions (%) 8.72%
Float 9.17M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.20

Current Ratio 0.20
Quick Ratio 0.08
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -66.05

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -145.66%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 129.29%
Revenue Per Employee n/a
Profits Per Employee -$10.19M
Employee Count 2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -45.20% in the last 52 weeks. The beta is 1.12, so NRXP's price volatility has been higher than the market average.

Beta (5Y) 1.12
52-Week Price Change -45.20%
50-Day Moving Average 2.68
200-Day Moving Average 2.26
Relative Strength Index (RSI) 43.27
Average Volume (20 Days) 502,353

Short Selling Information

The latest short interest is 1.03 million, so 8.56% of the outstanding shares have been sold short.

Short Interest 1.03M
Short Previous Month 1.21M
Short % of Shares Out 8.56%
Short % of Float 11.26%
Short Ratio (days to cover) 0.38

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -20.48M
Pretax Income -25.64M
Net Income -20.39M
EBITDA -20.47M
EBIT -20.48M
Earnings Per Share (EPS) -$2.12
Full Income Statement

Balance Sheet

The company has $1.65 million in cash and $6.04 million in debt, giving a net cash position of -$4.39 million or -$0.36 per share.

Cash & Cash Equivalents 1.65M
Total Debt 6.04M
Net Cash -4.39M
Net Cash Per Share -$0.36
Equity (Book Value) -18.82M
Book Value Per Share -1.66
Working Capital -16.19M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.73 million and capital expenditures $1,000, giving a free cash flow of -$11.73 million.

Operating Cash Flow -11.73M
Capital Expenditures 1,000
Free Cash Flow -11.73M
FCF Per Share -$0.97
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NRXP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -32.95%
Shareholder Yield -32.95%
Earnings Yield -62.15%
FCF Yield -35.76%

Analyst Forecast

The average price target for NRXP is $31.67, which is 1,118.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target $31.67
Price Target Difference 1,118.08%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on April 2, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date Apr 2, 2024
Split Type Reverse
Split Ratio 0.1:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1